• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常人和胃肠道癌症患者的OLFM4血浆水平。

Plasma levels of OLFM4 in normals and patients with gastrointestinal cancer.

作者信息

Clemmensen Stine N, Glenthøj Anders J, Heebøll Sara, Nielsen Hans Jørgen, Koch Claus, Borregaard Niels

机构信息

The Granulocyte Research Laboratory, Department of Hematology, National University Hospital, Copenhagen, Denmark.

Department of Pathology, National University Hospital, Copenhagen, Denmark.

出版信息

J Cell Mol Med. 2015 Dec;19(12):2865-73. doi: 10.1111/jcmm.12679. Epub 2015 Sep 28.

DOI:10.1111/jcmm.12679
PMID:26416558
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4687705/
Abstract

Olfactomedin 4 (OLFM4) is a secreted glycoprotein predominantly expressed in bone marrow and gastrointestinal tissues. Aberrant expression of OLFM4 has been shown in several cancers. However, the clinical significance hereof is currently controversial. OLFM4 has been proposed as a candidate biomarker of gastrointestinal cancers. To address this, we developed monoclonal antibodies against synthetic peptides representing various segments of OLFM4. We examined expression of OLFM4 in epithelial cells by immunohistochemistry and found that OLFM4 is highly expressed in proliferating benign epithelial cells and in some carcinoma cells. We developed an Enzyme Linked Immunosorbent Assay for OLFM4 and investigated whether plasma levels of OLFM4 reflect colorectal malignancies, but were unable to see any such association. Instead, we observed two populations of individuals with respect to OLFM4 levels in plasma, the majority with OLFM4 in plasma between 0 and 0.1 μg/ml, mean 0.028 μg/ml while 10% of both normals and patients with cancers had OLFM4 between 4 and 60 μg/ml, mean 15 μg/ml. The levels were constant over time. The background for this high plasma level is not known, but must be taken into account if OLFM4 is used as biomarker for GI cancers.

摘要

嗅觉介质蛋白4(OLFM4)是一种主要在骨髓和胃肠道组织中表达的分泌型糖蛋白。OLFM4在多种癌症中已显示出异常表达。然而,其临床意义目前存在争议。OLFM4已被提议作为胃肠道癌症的候选生物标志物。为解决这一问题,我们针对代表OLFM4不同片段的合成肽开发了单克隆抗体。我们通过免疫组织化学检测了OLFM4在上皮细胞中的表达,发现OLFM4在增殖的良性上皮细胞和一些癌细胞中高度表达。我们开发了一种针对OLFM4的酶联免疫吸附测定法,并研究了OLFM4的血浆水平是否反映结直肠癌,但未发现任何此类关联。相反,我们观察到血浆中OLFM4水平存在两类人群,大多数人的血浆OLFM4水平在0至0.1μg/ml之间,平均为0.028μg/ml,而正常人和癌症患者中各有10%的人的OLFM4水平在4至60μg/ml之间,平均为15μg/ml。这些水平随时间保持恒定。这种高血浆水平的原因尚不清楚,但如果将OLFM4用作胃肠道癌症的生物标志物,必须予以考虑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eeb/4687705/626b84e7b972/JCMM-19-2865-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eeb/4687705/4128ac69c5ab/JCMM-19-2865-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eeb/4687705/a45b45c074f1/JCMM-19-2865-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eeb/4687705/24fc1d93e9f7/JCMM-19-2865-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eeb/4687705/eca6f7834747/JCMM-19-2865-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eeb/4687705/626b84e7b972/JCMM-19-2865-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eeb/4687705/4128ac69c5ab/JCMM-19-2865-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eeb/4687705/a45b45c074f1/JCMM-19-2865-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eeb/4687705/24fc1d93e9f7/JCMM-19-2865-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eeb/4687705/eca6f7834747/JCMM-19-2865-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eeb/4687705/626b84e7b972/JCMM-19-2865-g005.jpg

相似文献

1
Plasma levels of OLFM4 in normals and patients with gastrointestinal cancer.正常人和胃肠道癌症患者的OLFM4血浆水平。
J Cell Mol Med. 2015 Dec;19(12):2865-73. doi: 10.1111/jcmm.12679. Epub 2015 Sep 28.
2
Olfactomedin 4, a novel marker for the differentiation and progression of gastrointestinal cancers.嗅鞘蛋白 4,一种用于胃肠道癌症分化和进展的新型标志物。
Neoplasma. 2011;58(1):9-13. doi: 10.4149/neo_2011_01_9.
3
Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients.血清嗅鞘蛋白4(GW112,hGC-1)与Reg IV联合检测是胃癌患者的一种高灵敏度生物标志物。
Int J Cancer. 2009 Nov 15;125(10):2383-92. doi: 10.1002/ijc.24624.
4
Low expression of olfactomedin 4 correlates with poor prognosis in smoking patients with non-small cell lung cancer.嗅觉介质蛋白4低表达与吸烟的非小细胞肺癌患者预后不良相关。
Hum Pathol. 2015 May;46(5):732-8. doi: 10.1016/j.humpath.2015.01.013. Epub 2015 Feb 12.
5
Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer.嗅觉介质蛋白4在固有免疫、炎症和癌症中的表达及功能
Cancer Metastasis Rev. 2016 Jun;35(2):201-12. doi: 10.1007/s10555-016-9624-2.
6
A neutrophil subset defined by intracellular olfactomedin 4 is associated with mortality in sepsis.一种由细胞内嗅觉素 4 定义的中性粒细胞亚群与脓毒症患者的死亡率相关。
Am J Physiol Lung Cell Mol Physiol. 2021 May 1;320(5):L892-L902. doi: 10.1152/ajplung.00090.2020. Epub 2020 Dec 23.
7
Olfactomedin 4 defines a subset of human neutrophils.嗅鞘蛋白 4 定义了人类中性粒细胞的一个子集。
J Leukoc Biol. 2012 Mar;91(3):495-500. doi: 10.1189/jlb.0811417. Epub 2011 Dec 20.
8
Olfactomedin-4 in digestive diseases: A mini-review.嗅鞘蛋白 4 在消化道疾病中的作用:一篇迷你综述。
World J Gastroenterol. 2018 May 7;24(17):1881-1887. doi: 10.3748/wjg.v24.i17.1881.
9
OLFM4 Expression in Ductal Carcinoma In Situ and in Invasive Breast Cancer Cohorts by a SWATH-Based Proteomic Approach.基于 SWATH 蛋白质组学方法检测管腔癌原位和浸润性乳腺癌队列中的 OLFM4 表达。
Proteomics. 2019 Nov;19(21-22):e1800446. doi: 10.1002/pmic.201800446. Epub 2019 Aug 8.
10
Olfactomedin 4-Positive Neutrophils Are Upregulated after Hemorrhagic Shock.嗅鞘蛋白 4 阳性中性粒细胞在失血性休克后上调。
Am J Respir Cell Mol Biol. 2021 Feb;64(2):216-223. doi: 10.1165/rcmb.2020-0276OC.

引用本文的文献

1
OLFM4 deficiency delays the progression of colitis to colorectal cancer by abrogating PMN-MDSCs recruitment.OLFM4 缺乏通过消除 PMN-MDSC 的募集来延缓结肠炎向结直肠癌的进展。
Oncogene. 2022 May;41(22):3131-3150. doi: 10.1038/s41388-022-02324-8. Epub 2022 Apr 29.
2
Olfm4 Is Highly Expressed in HCC Patients and as a Biomarker and Therapeutic Target for HCC.Olfm4 在 HCC 患者中高表达,可作为 HCC 的生物标志物和治疗靶点。
Can J Gastroenterol Hepatol. 2021 Dec 6;2021:5601678. doi: 10.1155/2021/5601678. eCollection 2021.
3
Longitudinal characterization of olfactomedin-4 expressing neutrophils in pediatric patients undergoing bone marrow transplantation.

本文引用的文献

1
Evaluation of complement proteins as screening markers for colorectal cancer.评估补体蛋白作为结直肠癌的筛查标志物。
Cancer Immunol Immunother. 2015 Jan;64(1):41-50. doi: 10.1007/s00262-014-1615-y. Epub 2014 Sep 27.
2
Robust cre-mediated recombination in small intestinal stem cells utilizing the olfm4 locus.利用olfm4基因座在小肠干细胞中进行强大的cre介导的重组。
Stem Cell Reports. 2014 Aug 12;3(2):234-41. doi: 10.1016/j.stemcr.2014.05.018. Epub 2014 Jun 26.
3
Papillon-Lefèvre syndrome patient reveals species-dependent requirements for neutrophil defenses.
在接受骨髓移植的儿科患者中,嗅鞘蛋白 4 表达中性粒细胞的纵向特征。
PLoS One. 2020 May 29;15(5):e0233738. doi: 10.1371/journal.pone.0233738. eCollection 2020.
4
Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer.嗅鞘蛋白 4 的下调与人类前列腺癌的肿瘤起始、生长和进展有关。
Int J Cancer. 2020 Mar 1;146(5):1346-1358. doi: 10.1002/ijc.32535. Epub 2019 Jul 9.
5
OLFM4 Inhibits Epithelial-Mesenchymal Transition and Metastatic Potential of Cervical Cancer Cells.OLFM4 抑制宫颈癌上皮-间质转化和转移潜能。
Oncol Res. 2019 Jul 12;27(7):763-771. doi: 10.3727/096504018X15399955297355. Epub 2019 Feb 14.
6
OLFM4, KNG1 and Sec24C identified by proteomics and immunohistochemistry as potential markers of early colorectal cancer stages.通过蛋白质组学和免疫组织化学鉴定出的OLFM4、KNG1和Sec24C作为早期结直肠癌阶段的潜在标志物。
Clin Proteomics. 2017 Mar 24;14:9. doi: 10.1186/s12014-017-9143-3. eCollection 2017.
7
Olfactomedin-4 Is a Candidate Marker for a Pathogenic Neutrophil Subset in Septic Shock.嗅觉介质蛋白4是脓毒症休克中致病性中性粒细胞亚群的候选标志物。
Crit Care Med. 2017 Apr;45(4):e426-e432. doi: 10.1097/CCM.0000000000002102.
掌跖角化-牙周破坏综合征患者揭示了中性粒细胞防御的物种依赖性需求。
J Clin Invest. 2014 Oct;124(10):4539-48. doi: 10.1172/JCI76009. Epub 2014 Sep 17.
4
In-depth proteomic delineation of the colorectal cancer exoproteome: Mechanistic insight and identification of potential biomarkers.结直肠癌外蛋白质组的深度蛋白质组学描绘:机制洞察与潜在生物标志物的鉴定
J Proteomics. 2014 May 30;103:121-36. doi: 10.1016/j.jprot.2014.03.018. Epub 2014 Mar 27.
5
Subcellular fractionation of human neutrophils and analysis of subcellular markers.人中性粒细胞的亚细胞分级分离及亚细胞标志物分析。
Methods Mol Biol. 2014;1124:53-76. doi: 10.1007/978-1-62703-845-4_5.
6
Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling.基于组织分泌组蛋白质组学分析鉴定的结直肠癌候选生物标志物。
J Proteomics. 2014 Mar 17;99:26-39. doi: 10.1016/j.jprot.2014.01.001. Epub 2014 Jan 10.
7
The human neutrophil subsets defined by the presence or absence of OLFM4 both transmigrate into tissue in vivo and give rise to distinct NETs in vitro.OLFM4 存在或缺失定义的人类中性粒细胞亚群既能在体内向组织迁移,也能在体外产生不同的 NETs。
PLoS One. 2013 Jul 29;8(7):e69575. doi: 10.1371/journal.pone.0069575. Print 2013.
8
Olfm4 deletion enhances defense against Staphylococcus aureus in chronic granulomatous disease.Olfm4 缺失增强慢性肉芽肿病患者对金黄色葡萄球菌的防御。
J Clin Invest. 2013 Sep;123(9):3751-5. doi: 10.1172/JCI68453. Epub 2013 Aug 1.
9
Olfactomedin 4 suppresses tumor growth and metastasis of mouse melanoma cells through downregulation of integrin and MMP genes.嗅鞘蛋白 4 通过下调整合素和 MMP 基因抑制小鼠黑色素瘤细胞的生长和转移。
Mol Cells. 2012 Dec;34(6):555-61. doi: 10.1007/s10059-012-0251-7. Epub 2012 Nov 15.
10
Olfactomedin 4 inhibits cathepsin C-mediated protease activities, thereby modulating neutrophil killing of Staphylococcus aureus and Escherichia coli in mice.嗅鞘蛋白 4 抑制组织蛋白酶 C 介导的蛋白酶活性,从而调节中性粒细胞对金黄色葡萄球菌和大肠杆菌的杀伤作用。
J Immunol. 2012 Sep 1;189(5):2460-7. doi: 10.4049/jimmunol.1103179. Epub 2012 Jul 27.